Intraoperative radiotherapy targets brain tumours with great precision. Over the past two decades, research funding has driven technical advances, addressing the challenges of treating glioblastoma. This therapy effectively controls microscopic disease and improves survival rates with manageable toxicity. Global studies assess its safety compared to standard treatments, highlighting the importance of cognitive function and timely systemic therapy. Ongoing research aims to improve its application.

Disclaimer: this video has been subtitled using AI software, so there may be some errors, if so please do not hesitate to report it to events@ecancer.org.